Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial.
J Clin Oncol
; 34(13): 1500-9, 2016 05 01.
Article
in En
| MEDLINE
| ID: mdl-26926681
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Transitional Cell
/
Antineoplastic Combined Chemotherapy Protocols
/
Urologic Neoplasms
/
Taxoids
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
2016
Document type:
Article
Country of publication:
United States